Anja Lunze explains the latest ruling of the CJEU on SPCs, concerning whether new formulations of an active ingredient can be protected.
We explore the practice of geographical licensing, by which the owner of the rights to a product grants to a licensee the exclusive right to develop and/or commercialise the product in a specific country or territory only.
Paul England explains the meaning of the ruling on inventive step in the UK Supreme Court decision Actavis v ICOS
Angus Milne reviews the decision by the UK Administrative Court to refuse a judicial review of the grant of a marketing authorisation for a generic medicinal product, DexEP.
Paul England provides the latest update on the date of Brexit and guidance from the MHRA and PMCPA on 'grandfathering'.